| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | SELECT SECTOR SPDR TR | 193,178 | 15,097,000 | 0.15% | ||
| 102 | GOLDCORP INC NEW | 1,292,672 | 14,943,000 | 0.15% | ||
| 103 | FRANCO NEVADA CORP | 320,382 | 14,657,000 | 0.14% | ||
| 104 | MACQUARIE INFRASTRUCTURE COR | 177,387 | 12,878,000 | 0.13% | ||
| 105 | IAC INTERACTIVECORP | 179,475 | 10,778,000 | 0.11% | ||
| 106 | KKR & CO LP COMMON UNITS | 643,170 | 10,027,000 | 0.10% | ||
| 107 | Ares Management, L.P. | 768,915 | 9,942,000 | 0.10% | ||
| 108 | CARLYLE GROUP L P | 587,129 | 9,171,000 | 0.09% | ||
| 109 | FIFTH STR SR FLOATNG RATE CO | 1,000,439 | 8,573,000 | 0.08% | ||
| 110 | APOLLO GLOBAL MGMT LLC | 545,980 | 8,288,000 | 0.08% | ||
| 111 | SEATTLE GENETICS INC | 180,224 | 8,088,000 | 0.08% | ||
| 112 | DYAX CORP COM CVR | 193,819 | 7,291,000 | 0.07% | ||
| 113 | PIMCO ETF TR | 68,842 | 6,926,000 | 0.07% | ||
| 114 | Anacor Pharmaceuticals Inc | 58,127 | 6,567,000 | 0.06% | ||
| 115 | NEUROCRINE BIOSCIE COM USD0.001 | 113,551 | 6,424,000 | 0.06% | ||
| 116 | ULTRAGENYX PHARMACEUTICAL INC COM | 51,159 | 5,739,000 | 0.06% | ||
| 117 | AKORN INCORPORATED | 150,749 | 5,624,000 | 0.05% | ||
| 118 | Oaktree Cap Grp Llc | 115,615 | 5,517,000 | 0.05% | ||
| 119 | YAMANA GOLD INC | 2,932,796 | 5,455,000 | 0.05% | ||
| 120 | ROYAL GOLD INC | 139,196 | 5,076,000 | 0.05% | ||
| 121 | NEWMONT CORP | 271,810 | 4,890,000 | 0.05% | ||
| 122 | INTERCEPT PHARMACEUTICALS INCORPORATED | 32,052 | 4,787,000 | 0.05% | ||
| 123 | ACADIA PHARMACEUTICALS INC COM | 132,936 | 4,739,000 | 0.05% | ||
| 124 | BARRICK GOLD CORP | 631,411 | 4,660,000 | 0.05% | ||
| 125 | RANDGOLD RES LTD | 74,293 | 4,601,000 | 0.04% | ||
| 126 | HORIZON PHARMA PLC | 209,845 | 4,547,000 | 0.04% | ||
| 127 | SIBANYE STILLWATER | 693,022 | 4,221,000 | 0.04% | ||
| 128 | PUBLIC STORAGE | 16,960 | 4,201,000 | 0.04% | ||
| 129 | CATALENT INC | 164,039 | 4,106,000 | 0.04% | ||
| 130 | IMPAX LABORATORIES INC | 92,892 | 3,972,000 | 0.04% | ||
| 131 | GOLD FIELDS LTD NEW | 1,410,465 | 3,907,000 | 0.04% | ||
| 132 | KITE PHARMA INCORPORATED | 62,977 | 3,881,000 | 0.04% | ||
| 133 | SIMON PPTY GROUP INC NEW | 19,725 | 3,835,000 | 0.04% | ||
| 134 | PORTOLA PHARMACEUTICALS INC | 73,548 | 3,784,000 | 0.04% | ||
| 135 | PACIRA PHARMACEUTICALS INC | 48,422 | 3,718,000 | 0.04% | ||
| 136 | NEW GOLD INC CDA | 1,584,361 | 3,676,000 | 0.04% | ||
| 137 | COLUMBIA PIPELINE GR | 182,822 | 3,656,000 | 0.04% | ||
| 138 | ELDORADO GOLD CORP NEW | 1,228,287 | 3,648,000 | 0.04% | ||
| 139 | EQUITY RESIDENTIAL | 44,565 | 3,636,000 | 0.04% | ||
| 140 | OPHTHOTECH CORP | 46,054 | 3,617,000 | 0.04% | ||
| 141 | DOMINION ENERGY INC | 52,054 | 3,521,000 | 0.03% | ||
| 142 | RADIUS HEALTH INCORPORATED COM NEW | 56,543 | 3,480,000 | 0.03% | ||
| 143 | ALAMOS GOLD INC NEW | 1,048,380 | 3,449,000 | 0.03% | ||
| 144 | MEDICINES CO | 91,482 | 3,416,000 | 0.03% | ||
| 145 | LIGAND PHARMACEUTICALS INC | 31,294 | 3,393,000 | 0.03% | ||
| 146 | GALAPAGOS NV | 51,393 | 3,232,000 | 0.03% | ||
| 147 | AGIOS PHARMACEUTICALS INC | 49,586 | 3,219,000 | 0.03% | ||
| 148 | BLUEBIRD BIO INC COM | 48,317 | 3,103,000 | 0.03% | ||
| 149 | ANGLOGOLD ASHANTI LIMITED | 435,010 | 3,089,000 | 0.03% | ||
| 150 | AVALONBAY COMM | 16,299 | 3,001,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001398344-16-009575, filed 2016.02.05).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
